8-K 1 d02729e8vk.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: JANUARY 27, 2003 COLORADO MEDTECH, INC. (Exact name of registrant as specified in its charter) COLORADO 000-12471 84-0731006 (State or other jurisdiction (Commission File I.R.S. Employer of incorporation) Number) Identification No.)
4801 NORTH 63RD STREET BOULDER, COLORADO 80301 ----------------------- (Address, including zip code, of principal executive offices) (303) 530-2660 -------------- (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS. Colorado MEDtech, Inc. issued a press release providing further detail regarding the sale of its Colorado operations. The text of the press release is attached hereto as Exhibit 99.1. ITEM 7. FINANCIAL STATEMENT AND EXHIBITS. (c) Exhibits. No. Description 99.1 Press release dated January 27, 2003 -2- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DATED, this 27th day of January, 2003. COLORADO MEDTECH, INC. By: /s/ Peter J. Jensen --------------------------------- Peter J. Jensen Vice President -3- INDEX TO EXHIBITS
EXHIBIT NUMBER DESCRIPTION ------- ----------- 99.1 Press release dated January 27, 2003